TFRC and cancer: In addition, as cancer cells usually require a far larger amount of iron than healthy cells and express a greater number of transferrin receptors [48,49,50], it was suggested that such transferrin-mediated uptake could impart some selectivity for cancer cells to ruthenium compounds.